Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Philipp Koehler and Oliver Cornely.
Philipp Koehler
Connection Strength
5.748
Oliver Cornely
  1. Diagnostic dilemma in COVID-19-associated pulmonary aspergillosis - Authors' reply. Lancet Infect Dis. 2021 06; 21(6):767-769.
    View in: PubMed
    Score: 0.932
  2. Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology. J Antimicrob Chemother. 2019 06 01; 74(6):1704-1712.
    View in: PubMed
    Score: 0.826
  3. Baseline predictors influencing the prognosis of invasive aspergillosis in adults. Mycoses. 2019 Aug; 62(8):651-658.
    View in: PubMed
    Score: 0.824
  4. Our 2014 approach to candidaemia. Mycoses. 2014 Oct; 57(10):581-3.
    View in: PubMed
    Score: 0.583
  5. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 06; 21(6):e149-e162.
    View in: PubMed
    Score: 0.230
  6. Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis-A simulation study. Mycoses. 2021 Jan; 64(1):55-59.
    View in: PubMed
    Score: 0.226
  7. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020 Jun; 63(6):528-534.
    View in: PubMed
    Score: 0.221
  8. Combination Antimicrobial Therapy for Enterococcus faecalis Infective Endocarditis. Clin Infect Dis. 2019 08 16; 69(5):900.
    View in: PubMed
    Score: 0.209
  9. Mould-reactive T cells for the diagnosis of invasive mould infection-A prospective study. Mycoses. 2019 Jul; 62(7):562-569.
    View in: PubMed
    Score: 0.206
  10. EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis. Mycoses. 2018 Nov; 61(11):833-836.
    View in: PubMed
    Score: 0.194
  11. Candida-Reactive T Cells for the Diagnosis of Invasive Candida Infection-A Prospective Pilot Study. Front Microbiol. 2018; 9:1381.
    View in: PubMed
    Score: 0.193
  12. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management. Mycoses. 2018 May; 61(5):326-330.
    View in: PubMed
    Score: 0.189
  13. Candida-reactive T cells for the diagnosis of invasive Candida infection of the lumbar vertebral spine. Mycoses. 2018 Jan; 61(1):48-52.
    View in: PubMed
    Score: 0.184
  14. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2021 Aug 26.
    View in: PubMed
    Score: 0.060
  15. EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19. Hemasphere. 2021 Jul; 5(7):e612.
    View in: PubMed
    Score: 0.060
  16. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021 08; 47(8):819-834.
    View in: PubMed
    Score: 0.060
  17. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol Med. 2021 08 09; 13(8):e14150.
    View in: PubMed
    Score: 0.059
  18. Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus. Microbiol Spectr. 2021 09 03; 9(1):e0001021.
    View in: PubMed
    Score: 0.059
  19. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 2021; 27(4):1077-1086.
    View in: PubMed
    Score: 0.058
  20. Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19. Immunity. 2020 12 15; 53(6):1258-1271.e5.
    View in: PubMed
    Score: 0.057
  21. COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J Fungi (Basel). 2020 Jun 24; 6(2).
    View in: PubMed
    Score: 0.056
  22. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020 Jun; 1(2):e53-e55.
    View in: PubMed
    Score: 0.055
  23. Rapid response infrastructure for pandemic preparedness in a tertiary care hospital: lessons learned from the COVID-19 outbreak in Cologne, Germany, February to March 2020. Euro Surveill. 2020 05; 25(21).
    View in: PubMed
    Score: 0.055
  24. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). J Antimicrob Chemother. 2019 11 01; 74(11):3315-3327.
    View in: PubMed
    Score: 0.053
  25. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr; 62(4):310-319.
    View in: PubMed
    Score: 0.050
  26. Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy. Int J Antimicrob Agents. 2018 Nov; 52(5):706-712.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.